Evidence map›Paper›PMID 28258198›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.

Rady J Laborde, Oraly Sanchez-Ferras, María C Luzardo, Yoelys Cruz-Leal, Audry Fernández, Circe Mesa, Liliana Oliver, Liem Canet, Liane Abreu-Butin, Catarina V Nogueira and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Liposome Formulations as Adjuvants for Vaccines.Current topics in microbiology and immunology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Rady J LabordeCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.ORCID 0000-0002-3227-2292
Oraly Sanchez-FerrasCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
María C LuzardoCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Yoelys Cruz-LealCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Audry FernándezImmunobiology Division, Center of Molecular Immunology, Havana 11600, Cuba.
Circe MesaImmunobiology Division, Center of Molecular Immunology, Havana 11600, Cuba.
Liliana OliverImmunobiology Division, Center of Molecular Immunology, Havana 11600, Cuba.ORCID 0000-0001-5308-7646
Liem CanetCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Liane Abreu-ButinDiscipline of Immunology, Department of Microbiology, Immunology, and Parasitology, Paulista Medical School, Federal University of São Paulo, São Paulo 04023-900, Brazil; and.
Catarina V NogueiraDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Mayra TejucaCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Fabiola PazosCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Carlos ÁlvarezCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
María E AlonsoCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba.
Ieda M Longo-MaugériDiscipline of Immunology, Department of Microbiology, Immunology, and Parasitology, Paulista Medical School, Federal University of São Paulo, São Paulo 04023-900, Brazil; and.ORCID 0000-0003-4184-8414
Michael N StarnbachDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Darren E HigginsDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Luis E FernándezImmunobiology Division, Center of Molecular Immunology, Havana 11600, Cuba; mlanio@fbio.uh.cu luis@cim.sld.cu.
María E LanioCenter for Protein Studies, Faculty of Biology, University of Havana, Havana 10400, Cuba; mlanio@fbio.uh.cu luis@cim.sld.cu.ORCID 0000-0002-1364-3713
University of Havana · CUCenter of Molecular Immunology (Cuba) · CUHarvard University · USUniversidade Federal de São Paulo · BR

Funding

Cytotoxic T Cell Mediated Immunity to ChlamydiaR01AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 2001 to 2025
$15.6M
The EPI-STI Biostatistics and Bioinformatics Core (Cuzick/Wheeler)U19AI113187 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI KONG, ALBERTA SUM-YU · 2014 to 2018
$12.6M
NIAID NIH HHS R01 AI039558NIAID NIH HHS U19 AI113187
6 · The paper itself

Abstract

Vaccine strategies to enhance CD8

Indexed as

Adjuvants, ImmunologicAnimalsCancer VaccinesCnidarian VenomsFemaleFlow CytometryLiposomesMiceMice, Inbred C57BLNeoplasms, ExperimentalT-Lymphocytes, CytotoxicAdjuvants, ImmunologicCancer VaccinesCnidarian VenomsLiposomessticholysin II

Identifiers

PMID28258198
PMCPMC5686032
OpenAlexW2593741016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.